Technology | December 22, 2014

Brainlab Multiple Metastases Planning Applications Now Available in the United States

Radiation oncologists and neurosurgeons can analyze, plan surgeries to maximize time and dose efficiencies

Brainlab, Adaptive Hybrid Surgery, Automatic Brain Metastasis Planning

Photo courtesy of Brainlab

December 22, 2014 — Brainlab announced U.S. Food and Drug Administration (FDA) 510(k) clearance for two software modules for radiation oncologists and neurosurgeons — Adaptive Hybrid Surgery and Automatic Brain Metastases Planning — to round out the Brainlab portfolio.

Adaptive Hybrid Surgery helps physicians balance surgical risk with radiosurgical toxicity for multidisciplinary treatment of skull-base tumors. A complete set of automated tools enables analysis of adjuvant radiosurgery at any time while planning and performing a surgical resection. Elements Intraoperative Structure Update captures residual tumor volumes based on points acquired inside the resection cavity. An intuitive traffic light display provides comprehensive information about tumor coverage and critical dose constraints for calculated treatment plans.

Automatic Brain Metastasis Planning software introduces technology that consistently and rapidly generates radiosurgery plans for the efficient treatment of multiple metastases. This allows clinicians to plan and treat multiple brain metastases with time and dose efficiencies while helping to minimize exposure to healthy surrounding tissue. Treatment delivery and planning time can be reduced drastically, even for as many as 10 metastatic tumors in the brain.

For more information: www.brainlab.com

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more